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Backgrounds and objectives
Animal models are necessary to test new antiviral drugs to
prevent CMV materno foetal transmission [1]. Among the
small animal CMV models, the guinea pig CMV (GPCMV)
has the ability to cross the placenta [2], causing disease in
utero [3,4]. The objective was to study the relation
between inoculum doses of guinea pig cytomegalovirus
(GPCMV) and the natural history of congenital disease in
the pregnant guinea pig model, by means of updated
ultrasound and virological methods.
Methods
1) Development of ultrasound examination for precise
assessment of the gestational age based on fetal crown-
rump length (CRL) measure.
2) Development of a real time PCR Taqman® GPCMV
based on the amplification of a sequence of the UL83
gene and determination of its sensitivity.
3) Subcutaneous administration at mid-gestation of two
doses (106 DI50 in group 1 and 108 DI50 in group 2 of
GPCMV strain obtained by cell culture in CMV-seronega-
tive pregnant Hartley strain guinea pigs. Serial sacrifice of
the animals were performed in the second part of the ges-
tation up to collect maternal tissues, maternal blood,
amniotic fluid, placenta and fetal tissues and to determine
the GPCMV load. Conventional histological examination
of the fetal infected tissues was performed.
Results
18 pregnant guinea pigs were included in group 1 and
nine in group 2.
1) Ultrasound examinations allowed the diagnosis of ges-
tations in the totality of the cases. A growth curve of
fetuses based on CRL was built.
2) The real time PCR GPCMV developed had sensitivity at
50% and 95% of 200 copies/mL and 2500 copies/mL
respectively, with a wide linear ranges up to 106 copies/
mL.
3) CMV infections were observed in 14/18 females in
group1 and in 9/9 females in group 2.
GPCMV maternal viremia was observed in 28% and 70%,
the median viral load was 100 and 700 copies/ml in
groups 1 and 2 respectively. The proportion of female
with at least one infected fetus in their litter was 0/18 and
2/9 (22.22%) in group 1 and 2 respectively (p= 0.103,
Fisher Exact Test).
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We developed an effective animal model using ultrasound
for determination of gestational age and a sensitive real
time GPCMV PCR for the diagnosis of GPCMV neonatal
infections. The acute infection with GPCMV in the guinea-
pig was reproduced in this model with materno-foetal
transmission. We show that the kinetics and the intensity
of the primary infection in the pregnant females as well as
the vertical transmission rate are related to the inoculum's
viral load. This model will be useful for further antiviral
CMV drug assays.
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